Mechanisms and Clinical Applications of Glucocorticoid Steroids in Muscular Dystrophy
Open Access
- 13 October 2020
- journal article
- review article
- Published by SAGE Publications in Journal of Neuromuscular Diseases
- Vol. 8 (1) , 39-52
Abstract
Glucocorticoid steroids are widely used as immunomodulatory agents in acute and chronic conditions. Glucocorticoid steroids such as prednisone and deflazacort are recommended for treating Duchenne Muscular Dystrophy where their use prolongs ambulation and life expectancy. Despite this benefit, glucocorticoid use in Duchenne Muscular Dystrophy is also associated with significant adverse consequences including adrenal suppression, growth impairment, poor bone health and metabolic syndrome. For other forms of muscular dystrophy like the limb girdle dystrophies, glucocorticoids are not typically used. Here we review the experimental evidence supporting multiple mechanisms of glucocorticoid action in dystrophic muscle including their role in dampening inflammation and myofiber injury. We also discuss alternative dosing strategies as well as novel steroid agents that are in development and testing, with the goal to reduce adverse consequences of prolonged glucocorticoid exposure while maximizing beneficial outcomes.Keywords
This publication has 150 references indexed in Scilit:
- VBP15, a novel anti‐inflammatory and membrane‐stabilizer, improves muscular dystrophy without side effectsEMBO Molecular Medicine, 2013
- VBP15, a Glucocorticoid Analogue, Is Effective at Reducing Allergic Lung Inflammation in MicePLOS ONE, 2013
- Annexin-A1 peptide down-regulates the leukocyte recruitment and up-regulates interleukin-10 release into lung after intestinal ischemia-reperfusion in miceJournal of Inflammation, 2013
- System among the corticosteroids: specificity and molecular dynamicsJournal of The Royal Society Interface, 2011
- The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insightsMolecular and Cellular Endocrinology, 2011
- Dexamethasone stimulates store-operated calcium entry and protein degradation in cultured L6 myotubes through a phospholipase A2-dependent mechanismAmerican Journal of Physiology-Cell Physiology, 2010
- Short-term prednisone use antagonizes insulin's anabolic effect on muscle protein and glucose metabolism in young healthy peopleAmerican Journal of Physiology-Endocrinology and Metabolism, 2009
- Effects of prednisolone on skeletal muscle contractility in mdx miceMuscle & Nerve, 2009
- The effects of glucocorticoid therapy on the inflammatory and Dendritic cells in muscular dystrophiesInternational Journal of Experimental Pathology, 2006
- Post‐translational modification plays an essential role in the translocation of annexin A1 from the cytoplasm to the cell surfaceThe FASEB Journal, 2006